These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 136010

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine.
    Trulson ME, Eubanks EE, Jacobs BL.
    J Pharmacol Exp Ther; 1976 Jul; 198(1):23-32. PubMed ID: 132525
    [Abstract] [Full Text] [Related]

  • 3. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
    Sloviter RS, Drust EG, Damiano BP, Connor JD.
    J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA, Chinn C, Proudfit HK, Anderson EG.
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [Abstract] [Full Text] [Related]

  • 7. LSD and CNS transmission.
    Aghajanian GK.
    Annu Rev Pharmacol; 1972 Apr; 12():157-68. PubMed ID: 4339014
    [No Abstract] [Full Text] [Related]

  • 8. Exposure to high pressure may produce the 5-HT behavioral syndrome in rats.
    Wardley-Smith B, Hudson S, Doré CJ, Charlett A, Fletcher A, Brammer NT, Minchin MC, Wann KT.
    Undersea Biomed Res; 1990 Jul; 17(4):275-86. PubMed ID: 1697708
    [Abstract] [Full Text] [Related]

  • 9. 5-Methoxytryptamine: stimulation of 5-HT receptors mediating the rat hyperactivity syndrome and blood platelet aggregation.
    Boullin DJ, Green AR.
    Adv Biochem Psychopharmacol; 1976 Jul; 15():127-40. PubMed ID: 15408
    [No Abstract] [Full Text] [Related]

  • 10. Behavioral evidence for denervation supersensitivity after destruction of central serotonergic nerve terminals.
    Trulson ME, Jacobs BL.
    Ann N Y Acad Sci; 1978 Jun 12; 305():497-509. PubMed ID: 309301
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. QSAR of agents involved in serotonin and LSD binding sites.
    Chan YL, Lien EJ, Shih JC.
    NIDA Res Monogr; 1978 Jun 12; (22):103-13. PubMed ID: 30904
    [No Abstract] [Full Text] [Related]

  • 14. Evidence that serotonin mediates some behavioral effects of amphetamine.
    Sloviter RS, Drust EG, Connor JD.
    J Pharmacol Exp Ther; 1978 Aug 12; 206(2):348-52. PubMed ID: 308099
    [Abstract] [Full Text] [Related]

  • 15. [The effect of several psychotropic substances on brain structure].
    Popova EN, Krivitskaia GN.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975 Aug 12; 75(7):1064-9. PubMed ID: 1210984
    [Abstract] [Full Text] [Related]

  • 16. Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats.
    Marona-Lewicka D, Kurrasch-Orbaugh DM, Selken JR, Cumbay MG, Lisnicchia JG, Nichols DE.
    Psychopharmacology (Berl); 2002 Oct 12; 164(1):93-107. PubMed ID: 12373423
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.